Amundi Asset Management US’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-117,758
| Closed | -$14.6M | – | 1567 |
|
|
2020
Q4 | $14.6M | Sell |
117,758
-7,076
| -6% | -$875K | 0.01% | 720 |
|
|
2020
Q3 | $12.2M | Sell |
124,834
-3,584
| -3% | -$349K | 0.01% | 678 |
|
|
2020
Q2 | $20M | Sell |
128,418
-10,379
| -7% | -$1.62M | 0.02% | 508 |
|
|
2020
Q1 | $20M | Sell |
138,797
-3,593
| -3% | -$519K | 0.03% | 403 |
|
|
2019
Q4 | $29.1M | Sell |
142,390
-43,801
| -24% | -$8.95M | 0.03% | 449 |
|
|
2019
Q3 | $14.9M | Buy |
186,191
+2,272
| +1% | +$182K | 0.02% | 599 |
|
|
2019
Q2 | $17.4M | Buy |
183,919
+49,814
| +37% | +$4.7M | 0.01% | 625 |
|
|
2019
Q1 | $11.5M | Buy |
+134,105
| New | +$11.5M | 0.02% | 671 |
|